{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:16:53Z","timestamp":1788333413394,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"he Health Commission of Guangxi Zhuang Autonomous Region","award":["Z20190534"],"award-info":[{"award-number":["Z20190534"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study aimed to investigate the association between antibiotic use and in-hospital mortality among patients with chronic kidney disease stage 5 (CKD5), to inform optimized antibiotic stewardship. A retrospective study was conducted on patients diagnosed with CKD5 in the nephrology department of a tertiary hospital in Guangxi, China, from January 2022 to December 2024. Patients with in-hospital mortality were matched with surviving controls using propensity score matching. Firth penalized logistic regression was employed to reduce small-sample bias, and\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -values were calculated to assess robustness to unmeasured confounding. Indicators of antibiotic use were then analyzed and compared between the 2 groups. A total of 3359 CKD5 patients were enrolled, with an in-hospital mortality rate of 0.98%. After propensity score matching (31 in-hospital mortality matched with 62 survivors), multivariable analysis showed that the number of antibiotic types used was significantly associated with in-hospital mortality (Firth odds ratio\u2005=\u20051.650, 95% CI: 1.148\u20132.492,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.006;\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -value\u2005=\u20051.889). This association was further supported by categorical analysis, where most antibiotic type categories showed significantly elevated mortality odds compared with no antibiotic use. Duration of antibiotic use (DOAU) was also significantly associated with mortality, though the effect size was modest (odds ratio\u2005=\u20051.081, 95% CI: 1.003\u20131.173,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.041). Multivariate regression analysis further clarified the factors influencing antibiotic use indicators: types of antibiotics used was significantly associated with number of pathogenic species, total duration of fever, and number of venous catheterizations. Separately, DOAU was associated with total duration of fever, ICU days, and number of pathogenic species . The number of antibiotic types used is independently associated with in-hospital mortality in patients with CKD5, with DOAU showing a modest but significant association. These results support more cautious antibiotic stewardship in patients with CKD5, including improving etiological testing before antibiotic administration and avoiding unnecessary increases in the number of antibiotic types used. Nevertheless, these findings warrant validation in larger prospective cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049833","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:02:09Z","timestamp":1784322129000},"page":"e49833","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between the number of antibiotic types used and in-hospital mortality in patients with chronic kidney disease stage 5: A propensity score-matched study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2579-8034","authenticated-orcid":false,"given":"Qiantu","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0549-0632","authenticated-orcid":false,"given":"Xuejiao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8166-8104","authenticated-orcid":false,"given":"Qiuhua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiang","family":"Lao","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1732-3466","authenticated-orcid":false,"given":"Yongxue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9691-7035","authenticated-orcid":false,"given":"Zhongqiu","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1482-9725","authenticated-orcid":false,"given":"Qianqian","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangxi Zhuangrong Region People\u2019s Hospital, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8996-4155","authenticated-orcid":false,"given":"Qianni","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2715-6650","authenticated-orcid":false,"given":"Limei","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Hospital Infection Management, Guangxi Zhuang Autonomous Region People\u2019s Hospital, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"R2-20260902","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth china chronic disease and risk factor surveillance.","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Internal Med"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019.","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"2540021","DOI":"10.1080\/07853890.2025.2540021","article-title":"The mortality of chronic kidney disease in Chinese subjects: a 12-year cohort based on clinical data in electronic health record.","volume":"57","author":"Niu","year":"2025","journal-title":"Ann Med"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14740338.2024.2443780","article-title":"Use of antibiotics in patients with chronic kidney disease: evidence from the real world.","volume":"25","author":"Valladales-Restrepo","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/medicina59010049","article-title":"Chronic kidney disease, urinary tract infections and antibiotic nephrotoxicity: are there any relationships?","volume":"59","author":"Dicu-Andreescu","year":"2022","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"R7-20260902","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","article-title":"Nephrotoxicity of antimicrobials and antibiotics.","volume":"27","author":"Morales-Alvarez","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1681\/ASN.2006040406","article-title":"Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States.","volume":"18","author":"Chavers","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl 2","key":"R9-20260902","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update.","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"e2224892","DOI":"10.1001\/jamanetworkopen.2022.24892","article-title":"Association of higher-dose fluoroquinolone therapy with serious adverse events in older adults with advanced chronic kidney disease.","volume":"5","author":"Muanda","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2013.09.009","article-title":"Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.","volume":"63","author":"Farag","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ndt\/gfy072","article-title":"Nephrology comanagement and the quality of antibiotic prescribing in primary care for patients with chronic kidney disease: a retrospective cross-sectional study.","volume":"34","author":"Zhu","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","article-title":"Overview of antibiotic-induced nephrotoxicity.","volume":"8","author":"Campbell","year":"2023","journal-title":"Kidney Int Reports"},{"key":"R14-20260902","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s40262-025-01587-0","article-title":"Clinical pharmacokinetic-pharmacodynamic relationships of pharmacological strategies for attenuating p-cresyl sulfate in patients with kidney disease.","volume":"64","author":"Dhungana","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"R15-20260902","first-page":"550","article-title":"Drug-induced acute kidney injury: diverse mechanisms of tubular injury.","volume":"25","author":"Perazella","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.jmedchem.5b01593","article-title":"Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B.","volume":"59","author":"Gallardo-Godoy","year":"2016","journal-title":"J Med Chem"},{"key":"R17-20260902","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41581-025-00958-x","article-title":"Innate immune cells in acute and chronic kidney disease.","volume":"21","author":"Meng","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev-immunol-090122-045843","article-title":"Immunology of kidney disease.","volume":"42","author":"Foresto-Neto","year":"2024","journal-title":"Annu Rev Immunol"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/toxins18020104","article-title":"Chronic kidney disease-associated defect in humoral immune response is driven by inflammation.","volume":"18","author":"Espi","year":"2026","journal-title":"Toxins"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.3390\/ijms22116109","article-title":"The mechanism of drug nephrotoxicity and the methods for preventing kidney damage.","volume":"22","author":"Kwiatkowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkz325","article-title":"Mechanisms of antimicrobial-induced nephrotoxicity in children.","volume":"75","author":"Downes","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/jcm10020196","article-title":"Clostridioides difficile infection in chronic kidney disease-An overview for clinicians.","volume":"10","author":"Dudzicz","year":"2021","journal-title":"J Clin Med"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10875-025-01890-2","article-title":"Chronic kidney disease in common variable immunodeficiency: a multicenter study.","volume":"45","author":"De Renzis","year":"2025","journal-title":"J Clin Immunol"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.trsl.2016.08.008","article-title":"Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance.","volume":"181","author":"Rani","year":"2017","journal-title":"Transl Res"},{"key":"R25-20260902","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11255-021-02834-6","article-title":"Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review.","volume":"54","author":"Chahine","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2215\/CJN.10710918","article-title":"Clinical outcomes of failing to dose-reduce cephalosporin antibiotics in older adults with CKD.","volume":"14","author":"Bathini","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/pds.4960","article-title":"Identifying drug combinations associated with acute kidney injury using association rules method.","volume":"29","author":"Nishtala","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s11606-019-05557-8","article-title":"Use of potentially nephrotoxic medications by U.S. adults with chronic kidney disease: NHANES, 2011-2016.","volume":"35","author":"Kurani","year":"2020","journal-title":"J Gen Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:00:48Z","timestamp":1788332448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":28,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049833","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-12-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}